Company / Shareholders' Equity
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.3M
FY2025
5-year range
$5.3M / $791.0M
FY2021-FY2025
Trend
-98.9%
vs FY2024
Sector context
#151 of 161
Health Care
What the data says
Among 161 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 6% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from $5M in FY2025 to $791M in FY2021.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -56.3%.
Declined from $701M to $5M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -78.8%
- 5-Year CAGR
- -56.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 161This company $5.3M Sector average $5.1B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -56.3%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 98.9% year-over-year.
- Ranks #151 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.3M | -98.9% |
| FY2024 | $506.6M | -27.8% |
| FY2023 | $701.3M | +24.6% |
| FY2022 | $562.9M | -28.8% |
| FY2021 | $791.0M | +135.8% |
| FY2020 | $335.5M | +510.9% |
| FY2019 | $54.9M | -51.9% |
| FY2018 | $114.1M | +32.5% |
| FY2017 | $86.1M | +1.7% |
| FY2016 | $84.7M | +22.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026